Assessment the extent of use of the COVID-19 vaccines as causes blood clots in COVID-19 patients by measuring blood parameters and fibrinogen levels

Read full text Summarise with VIRAT
Authors: Emad A. Nourelgalil, Reem E Mohammed, Abdalla M. Abdalla, Tariq E Elmissbah
Cited by: 0
References: 12

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background and Objective: Notably, viral infections spread rapidly over the world and are associated with a variety of consequences that result in morbidity and mortality among immune compromised patients. Not unexpectedly, SARS-Cov-2 is one of the most aggressive viral illnesses, and it is associated with an elevated risk of death, particularly among the elderly and those with limited immunity. As a result, there is a rising need to reduce the number of deaths caused by the immune system with vaccinations, yet there is less evidence concerning vaccine function and efficacy. The purpose of this study is to assess the impact of COVID-19 vaccinations on fibrinogen levels and complete blood count among COVID patients. Materials & Methods: This is an analytical, cross-sectional study carried out in Khartoum city. 140 samples are taken from healthy individuals, with 70 collected before and 70 collected after vaccination. The fibrinogen level was determined among research groups using a BIOBASE Coagulometer, and the complete blood count was performed using a MindrayBC-3000Plus. Results: It was observed that most mean test values were higher in the pre-vaccination phase compared to the post-vaccination phase, with the exceptions of mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and platelets count, which exhibited higher means post-vaccination. All associations were found to be insignificant, with p-values greater than 0.05, except for red blood cells count, which demonstrated a significant p-value of 0.002. The fibrinogen test results indicated a mean of 302.0 ± 97.9 for pre-vaccination, surpassing the post-vaccination mean of 262.8 ± 62.4, yielding a significant p-value of 0.005 for this association. Conclusion: A significant drop in fibrinogen levels shortly after the first week of vaccination indicates a noteworthy correlation, along with a minor decrease in other blood counts, especially a marked association seen in red blood cells following vaccination.

Fields of Study & Subjects

COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research Blood properties and coagulation

Publication details

Journal / source
International Journal of Pharmacology and Clinical Research
Volume
8
Issue
3
Pages
138–141
Publication date
1 March 2026
Language
EN